AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2016

Aug 11, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2016-08-10

Reporting Person: Cole Douglas G. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-10	Common Stock	J	917	—	Acquired	2778	Direct

Footnotes

F1: On August 10, 2016, Flagship Ventures Fund 2007, L.P. ("Flagship 2007") distributed to its limited partners and sole general partner, Flagship Ventures 2007 General Partner, LLC ("Flagship GP"), pro rata and without consideration, certain shares of the Issuer's common stock. Flagship GP, in turn, distributed to its members, pro rata and without consideration, the shares it received from Flagship 2007. Mr. Cole, a member of Flagship GP, received 917 shares through such distribution.